Acute neurite retraction elicited by diverse agents is prevented by genistein, a tyrosine kinase inhibitor.
The retraction of axonal branches is a prominent feature of nervous system development and function. Although various biological and pathological signals can elicit retraction, little is known regarding their underlying mode of action. An in vitro assay using NG108-15 cells was used to demonstrate that rapid-onset neurites exposed acutely to trypsin, serum, lysophosphatidic acid, extracellular ATP, the phorbol ester phorbol 12-myristate 13-acetate, and nocodazole were all protected from retraction by the tyrosine kinase inhibitor genistein. This finding indicates that a common (genistein-sensitive) cellular event is involved in integrating the influence of multiple extrinsic and intrinsic signals and in regulating whether or not neurites will execute a retraction response.
Department of Pediatrics, University of Chicago, Illinois 60637.
N R
NR
Smalheiser
D002478:Cells, Cultured; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D019833:Genistein; D007529:Isoflavones / Q000494:pharmacology*; D016501:Neurites / Q000187:drug effects* / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D013268:Stimulation, Chemical; D013997:Time Factors
D003470:Culture Media; D007529:Isoflavones; D019833:Genistein; D011505:Protein-Tyrosine Kinases